The therapeutic options in systemic sclerosis (SSc) are limited mainly to the management of
complications, and decelerating fibrosis and preventing disease progression are still great …

The treatment of progressive systemic sclerosis (PSS) is still unsatisfactory. We report on
clinical, laboratory and immunological findings in 26 patients with PSS (6 males, 20 women) …

Background/purpose: Extracorporeal photochemotherapy (ECP) has been proposed for the
treatment of various auto‐and allo‐immune reactions. However, a standard ECP regimen …

Background: The management of systemic sclerosis remains unsatisfactory. Thus far, the
action of extracorporeal photopheresis (ECP) in severe systemic scleroderma has been …

The aim of this study was to evaluate the clinical and immunomodulatory effects of
extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 …

Background: Scleroderma is a heterogeneous group of diseases that can be localized or
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …

Background: Extracorporeal photopheresis (ExP) is an effective therapy for several
conditions including cutaneous T-cell lymphoma, scleroderma, and allograft rejection …

Objective. To investigate the effectiveness and feasibility of extracorporeal
photochemotherapy (ECP) in the treatment of an autoimmune disease with known …

Although several case reports and case series have suggested efficacy for photopheresis in
the treatment of autoimmune diseases, few controlled studies have been conducted to test …

Systemic scleroderma—also known as systemic sclerosis (SS c)—is a chronic systemic
connective tissue disease characterized by collagen deposition in cutaneous and internal …